1. Home
  2. MUSA vs IBRX Comparison

MUSA vs IBRX Comparison

Compare MUSA & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Murphy USA Inc.

MUSA

Murphy USA Inc.

HOLD

Current Price

$504.48

Market Cap

9.2B

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.41

Market Cap

8.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUSA
IBRX
Founded
1996
2014
Country
United States
United States
Employees
16900
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
8.4B
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
MUSA
IBRX
Price
$504.48
$7.41
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$458.43
$12.57
AVG Volume (30 Days)
343.9K
24.4M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
0.51%
N/A
EPS Growth
N/A
38.71
EPS
24.10
N/A
Revenue
$21,529,400,000.00
$113,288,000.00
Revenue This Year
$17.24
$88.59
Revenue Next Year
$3.49
$131.15
P/E Ratio
$20.43
N/A
Revenue Growth
N/A
668.31
52 Week Low
$345.23
$1.83
52 Week High
$523.09
$12.43

Technical Indicators

Market Signals
Indicator
MUSA
IBRX
Relative Strength Index (RSI) 74.06 45.27
Support Level $357.92 $2.25
Resistance Level N/A $8.28
Average True Range (ATR) 15.39 0.89
MACD 4.43 -0.25
Stochastic Oscillator 99.99 28.17

Price Performance

Historical Comparison
MUSA
IBRX

About MUSA Murphy USA Inc.

Murphy USA Inc is mainly engaged in the marketing of retail motor fuel products and convenience merchandise through a network of several retail stores in the Southwest, Southeast, Midwest, and Northeast United States. The majority of Murphy USA's stores are located in proximity to Walmart Supercenters, but it also operates standalone stores that market gasoline and other products under the Murphy USA, Murphy Express, and QuickChek brands. In addition, the company also markets fuel to unbranded wholesale customers through a mixture of company-owned and third-party product distribution terminals and pipeline positions. The firm generates maximum revenue through retail sales of petroleum products, and the rest from merchandise sales and wholesale of petroleum products.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: